# Bacterial enzyme-responsive hydrogels for triggered delivery of antibiotics to infected wounds

**Authors:** Akram Abbasi, Alec McCall, Zhaowei Jiang, Brian W. LeBlanc, Anita Shukla

PMC · DOI: 10.1126/sciadv.adz0786 · 2026-03-20

## TL;DR

A hydrogel that releases antibiotics only in the presence of bacterial enzymes can effectively treat infected wounds and reduce antibiotic resistance.

## Contribution

A β-lactamase–responsive hydrogel that enables on-demand antibiotic delivery specifically at infection sites.

## Key findings

- The hydrogel selectively degrades and releases antibiotics in the presence of β-lactamase-producing bacteria.
- In a mouse model, the hydrogel achieved complete bacterial eradication and improved wound healing.
- The hydrogel did not induce antibiotic resistance in non–β-lactamase–producing bacteria.

## Abstract

Wound infections are becoming increasingly difficult to treat due to rising antibiotic-resistant bacteria. β-Lactamase–producing bacteria are among the most common pathogens implicated in these infections. Here, we report a bacterial enzyme-responsive hydrogel formulated with a cephalosporin-derived, β-lactamase–cleavable crosslinker that undergoes selective degradation in the presence of bacterial β-lactamases. This degradation triggers the on-demand release of encapsulated ciprofloxacin-loaded liposomes, ensuring that antibiotic delivery occurs only at the site of infection. This selective degradation and release was demonstrated in both ex vivo and in vivo models of Pseudomonas aeruginosa wound infections. In a murine skin abrasion infection model, a single application of the hydrogel led to complete bacterial eradication and enhanced wound healing, outperforming a commercial silver-based hydrogel wound dressing. These responsive hydrogels did not induce ciprofloxacin resistance in non–β-lactamase–producing bacteria. These findings demonstrate that β-lactamase–responsive hydrogels provide a precise, infection-triggered antibiotic delivery platform that can improve the treatment of wound infections and mitigate antimicrobial resistance.

Hydrogel delivers antibiotics on-demand to infected wounds in response to bacterial enzymes mitigating antimicrobial resistance.

## Linked entities

- **Chemicals:** cephalosporin (PubChem CID 25058126), ciprofloxacin (PubChem CID 2764)
- **Species:** Pseudomonas aeruginosa (taxon 287), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Beta-Lactamase [NCBI Gene 4290808], beta-lactamase [NCBI Gene 13913583]
- **Diseases:** skin (MESH:D012871), inflammation (MESH:D007249), swelling (MESH:D004487), Klebsiella pneumoniae (MESH:D007710), abrasion (MESH:D065306), burn wound infection (MESH:D014946), skin and soft tissue infections (MESH:D018461), burn (MESH:D002056), Bacterial (MESH:D001424), deaths (MESH:D003643), tissue damage (MESH:D017695), Burn wounds (MESH:D014947), infected (MESH:D007239), bleeding (MESH:D006470), hemolysis (MESH:D006461)
- **Chemicals:** sodium sulfate (MESH:C012036), agar (MESH:D000362), saline (MESH:D012965), Lipid (MESH:D008055), maleimide (MESH:C043592), beta-Lactam (MESH:D047090), N2 (MESH:D009584), carbapenems (MESH:D015780), silica gel (MESH:D058428), Schiff base (MESH:D012545), (NH4)2SO4 (MESH:D000645), ceftazidime (MESH:D002442), silver (MESH:D012834), glycerol (MESH:D005990), Cy5 (MESH:C085321), water (MESH:D014867), diethyl ether (MESH:D004986), Silvasorb (MESH:C500575), N-methylmorpholine (MESH:C038816), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-(methoxy(polyethylene glycol)-2000) (MESH:C519184), R (MESH:D001120), ammonium (MESH:D064751), cefazolin (MESH:D002437), aztreonam (MESH:D001398), CO2 (MESH:D002245), glutaraldehyde (MESH:D005976), 4-aminothiophenol (MESH:C064316), HATU (MESH:C472082), HCl (MESH:D006851), paraformaldehyde (MESH:C003043), imipenem (MESH:D015378), amoxicillin (MESH:D000658), ethyl acetate (MESH:C007650), DIPEA (MESH:C027070), phospholipid (MESH:D010743), thiol (MESH:D013438), chloroform (MESH:D002725), nitrocefin (MESH:C021720), TEA (MESH:C016162), beta-lactam antibiotics (MESH:D008997), polydimethylsiloxane (MESH:C013830), acetone (MESH:D000096), polystyrene (MESH:D011137), methanol (MESH:D000432), fluoroquinolone (MESH:D024841), H&amp;E (MESH:D006371), H2O2 (MESH:D006861), rhodamine B (MESH:C029773), oxygen (MESH:D010100), penicillin (MESH:D010406), DCM (MESH:D008752), Triton X-100 (MESH:D017830), DMSO (MESH:D004121), lissamine rhodamine B (MESH:C022027), ethanol (MESH:D000431), anisole (MESH:C060998), BioRender (-), methicillin (MESH:D008712), DMF (MESH:D004126), Alexa 568 (MESH:C000607448)
- **Species:** Bacillus cereus (species) [taxon 1396], Klebsiella pneumoniae (species) [taxon 573], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Hathewaya histolytica (species) [taxon 1498], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Mus musculus (house mouse, species) [taxon 10090], Staphylococcus aureus (species) [taxon 1280], Pseudomonas aeruginosa PAO1 (strain) [taxon 208964], Acinetobacter baumannii (species) [taxon 470], Burkholderia cepacia (species) [taxon 292], Pseudomonas aeruginosa (species) [taxon 287]
- **Mutations:** S007668790591015X
- **Cell lines:** S13A — Homo sapiens (Human), Conditionally immortalized cell line (CVCL_LF75), Xen29 — Homo sapiens (Human), Amyotrophic lateral sclerosis 1, Induced pluripotent stem cell (CVCL_8999), NIH 3T3 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13004048/full.md

---
Source: https://tomesphere.com/paper/PMC13004048